Medicamen Organics Ltd (MEDIORG) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: MEDIORG | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

Medicamen Organics Ltd (MEDIORG) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: MEDIORG | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Medicamen Organics

Based on:

M-Cap below 100cr DeciZen not available

Medicamen Organics stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
9.64
Market Cap:
31.5 Cr.
52-wk low:
0
52-wk high:
0

Is Medicamen Organics Ltd an attractive stock to invest in?

1. Is Medicamen Organics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medicamen Organics Ltd is a below average quality company.

2. Is Medicamen Organics Ltd undervalued or overvalued?

The key valuation ratios of Medicamen Organics Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Medicamen Organics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medicamen Organics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Medicamen Organics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medicamen Organics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 5.7%4.1%10.1%20.9%14.1%-
Value Creation
Index
-0.6-0.7-0.30.50.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 25.12122.225.337.137
Sales YoY Gr.--16.3%5.6%14.1%46.8%-
Adj EPS 0.50.21.63.12.82.8
YoY Gr.--66%858.8%87.1%-8.2%-
BVPS (₹) 12.513.41517.724.824.8
Adj Net
Profit
0.30.112.63.33
Cash Flow from Ops. -1.20-0.6-3.7-4.9-
Debt/CF from Ops. -8.2274-20.2-3.5-2.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA20.9%46.8%
Adj EPS NANA154.4%-8.2%
BVPSNANA22.9%39.6%
Share Price - - - -53.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
41.311.521.614.611.3
Op. Profit
Mgn %
6.55.78.518.815.1NAN
Net Profit
Mgn %
1.20.54.410.48.98.8
Debt to
Equity
1.31.31.30.80.4-
Working Cap
Days
02603053513390
Cash Conv.
Cycle
053801501590

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 20.92%

Net Profit is growing at healthy rate in last 3 years 154.43%

Debt to equity has declined versus last 3 years average to 0.42

Return on Equity has declined versus last 3 years average to 11.30%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Medicamen Organics Ltd.

Standalone Consolidated
TTM EPS (₹) 2.8 3.5
TTM Sales (₹ Cr.) 37.1 38.2
BVPS (₹.) 24.8 25.1
Reserves (₹ Cr.) 17 18
P/BV 1.09 1.07
PE 9.64 7.79
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 31.5
Equity (₹ Cr.) 11.7
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Medicamen Organics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Medicamen Organics - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Medicamen Organics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Sales25.0520.9822.1525.2737.09
Operating Expenses 23.4119.7820.2820.5331.52
Manufacturing Costs6.1610.025.846.7012.91
Material Costs12.605.649.969.1711.97
Employee Cost 2.332.492.872.993.23
Other Costs 2.321.631.611.683.40
Operating Profit 1.631.201.874.745.57
Operating Profit Margin (%) 6.5%5.7%8.4%18.7%15.0%
Other Income 0.010.210.821.070.10
Interest 0.480.470.610.650.54
Depreciation 0.680.680.710.720.74
Exceptional Items 00000
Profit Before Tax 0.490.261.364.444.39
Tax 0.190.150.391.811.12
Profit After Tax 0.300.100.972.623.27
PAT Margin (%) 1.2%0.5%4.4%10.4%8.8%
Adjusted EPS (₹)0.50.21.63.12.8
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 7.478.018.9815.2628.97
Share Capital 6668.6011.70
Reserves 1.472.012.986.6617.27
Minority Interest00000
Debt9.069.8211.4812.4911.99
Long Term Debt0.640.640.330.160.16
Short Term Debt8.429.1811.1512.3311.83
Trade Payables7.027.3197.0811.67
Others Liabilities 2.802.393.133.614.81
Total Liabilities 26.3427.5432.5938.4457.44

Fixed Assets

Gross Block15.8416.4616.741818.37
Accumulated Depreciation4.485.165.887.658.24
Net Fixed Assets 11.3511.2910.8710.3510.13
CWIP 0000.152.22
Investments 00000.27
Inventories2.664.726.146.147.49
Trade Receivables7.536.2510.7716.7024.75
Cash Equivalents 0.880.440.530.553.27
Others Assets 3.924.844.284.559.32
Total Assets 26.3427.5432.5938.4457.44

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1.160.04-0.58-3.66-4.91
PBT 0.490.261.363.394.39
Adjustment 1.5710.531.351.02
Changes in Working Capital -3.18-1.15-2.43-8.22-10.22
Tax Paid -0.05-0.07-0.05-0.18-0.09
Cash Flow From Investing Activity -0.02-0.59-0.28-0.34-2.62
Capex -0.03-0.62-0.29-0.35-2.45
Net Investments 00000
Others 0.010.020.010.01-0.18
Cash Flow From Financing Activity 1.270.180.944.0110.25
Net Proceeds from Shares 0003.8010.54
Net Proceeds from Borrowing 00-0.31-0.39-0
Interest Paid -0.48-0.47-0.61-0.65-0.51
Dividend Paid 00000
Others 1.750.651.861.250.23
Net Cash Flow 0.09-0.370.070.022.72

Finance Ratio

PARTICULARSMar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.991.3111.4121.6514.79
ROCE (%)5.674.1310.1120.8814.13
Asset Turnover Ratio0.950.780.740.710.77
PAT to CFO Conversion(x)-3.870.4-0.6-1.4-1.5
Working Capital Days
Receivable Days110120140198204
Inventory Days3964908967
Payable Days203463299320286

Medicamen Organics Ltd Stock News

Medicamen Organics Ltd FAQs

The current trading price of Medicamen Organics on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Medicamen Organics stood at ₹31.53.
The latest P/E ratio of Medicamen Organics as of 31-Dec-1969 is 9.64.
The latest P/B ratio of Medicamen Organics as of 31-Dec-1969 is 1.09.
The 52-week high of Medicamen Organics is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medicamen Organics is ₹37.09 ( Cr.) .

About Medicamen Organics Ltd

Medicamen Organics Limited was incorporated on March 15, 1995 as ‘Panchdeep Pharmaceuticals Limited’, a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated March 15, 1995 issued by the Registrar of Companies, National Capital Territory (NCT) of Delhi and Haryana. The company has received Certificate of Commencement of Business on March 15, 1995, issued by the Registrar of Companies, National Capital Territory (NCT) of Delhi and Haryana. Subsequently, pursuant to a resolution passed by the Board of Directors in their meeting held on July 31, 1995 and by the Shareholders in their EGM held on October 14, 1995, the name of the Company was changed to ‘Medicamen Organics Limited’ and a fresh certificate of incorporation dated November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi.

Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. It markets its product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis. Its products are marketed across India as well as African, CIS and south East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by its third-party distributor.

Its manufacturing facilities are capable of producing pharmaceutical formulations and products and has fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing process. It has in-house testing laboratory and necessary infrastructure to test its raw materials and finished products to match the quality standards. Its core strength lies in product development and documentation, it is regularly engaged in research and development and launching new products. This gives it an exhaustive product list as well as fair pricing in the market. Its product portfolio consists of comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS).

Business area of the company

The company is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.

Products category

  • Capsules
  • Ointment/external preparation
  • Suspension
  • Dry powder sachet
  • Tablet

Awards and accreditations

  • 2015: ISO 9001:2015 - Manufacture and Supply of Food Supplement for Human use and Non Beta Lactum Tablets, Capsules, Liquid and Ointments (Unit II). 
  • 2015: ISO 9001: 2008 Manufacture and Supply of Food Supplement for Human Use (Unit II). 
  • 2010: ISO 9001: 2008 (Quality Management System). 
  • 2018. ISO 9001:2015 certified company (Unit I) Manufacture and Supply of Tablets, Capsules and Liquid Orals for both Domestic and Export Market.

History and milestones

  • 1995: The company was incorporated as a Public Limited company under the name ‘Panchdeep Pharmaceuticals Limited’ and later the company has changed its name from ‘Panchdeep Pharmaceuticals Limited’ to ‘Medicamen Organics Limited’.
  • 1996: It started with trading of pharmaceuticals for supplies to various Government departments.
  • 1998-2007: It took loan license with ‘M/s Rhydurg Pharmaceuticals’, a unit situated in Kundali across the border of Delhi and started getting product manufactured for its marketing.
  • 2007: It purchased a plot of land measuring 1200 square meter from SIDCUL Industrial Authority in Haridwar and started construction for its own pharma unit. The construction of three-storeyed building (including basement measuring 15000 sq. feet was completed and it got its own manufacturing license for tablets, capsules, oral liquids in form 25 and 28 and started its owns production in the same year (UNIT-I).
  • 2007: It received WHO/GMP Certificate for Unit I.
  • 2010: It applied for a license for manufacturing of food supplements, like protein powders, vitamin tablets and syrups etc. and got its first license.
  • 2017: It received WHO/GMP Certificate for Unit I.
  • 2017: It got an opportunity to purchase one readymade adjacent unit to shift its food production in a separate unit. It got its first license in this Unit and tied up with renowned Pharma company for one of their renowned products for manufacturing in its plant. This unit was termed as (UNIT-II).
  • 2017: It stopped production of general pharma products in Unit-I and converted it into a unit for exclusive production of Iron Tablets because of its huge world-wide demand.

You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×